AstraZeneca to pay $110 million in fraudulent marking case

AstraZeneca has reached a settlement in two lawsuits claiming the drugmaker falsely marketed one of its products and manipulated the Medicaid program in Texas.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news